ATAI Life Science's IPO in 2021 is expected to be another big industry catalyst. But one company that might NOT benefit is Compass Pathways.
Numinus Wellness Inc. Announces $10 Million Bought Deal Public Offering
Numinus announces a bought deal financing at CAD$0.68 cents.
Prominent Bitcoin Investor’s Next Monster Bet
One of Bitcoin’s most prominent investors is making a new monster bet.
BIG Financings Powering Future Profits in Psychedelic Stocks
Nearly $400 million dollars has recently flooded into the coffers of psychedelic drug companies. That's enough capital to power a lot of growth.
Oregon wants experts for new psilocybin-assisted therapy board
Oregon’s effort to create a new psilocybin-assisted therapy system has attracted attention from across the country.
Mind Cure Announces Eligibility for DTC Trading
Mind Cure stock is now much more easily accessible for U.S.-based investors.
Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial
Numinus' Vancouver clinic will be used for collaboration on a clinical trial with MAPS for MDMA-assisted therapy for PTSD.
Entheon Biomedical Announces CRO Agreement with CHDR for Phase 1 Clinical Trial; Centre for Human Drug Research Led DMT Study to Start in 2021
Entheon announces an agreement for the purpose of conducting a Phase 1 clinical trial.
The Psychedelics Revolution: It’s No Longer BAD To Feel GOOD
A Psychedelic Drug Revolution is occurring -- to bring badly needed psychedelic medicines to a world suffering from a Mental Health Crisis.
Entheon Biomedical to Begin Trading on the Frankfurt Exchange
Entheon adds a German listing to its original CSE listing.
MindMed Announces 2nd $25 Million Bought Deal Public Offering
MindMed's most recent financing is at nearly double where it priced units just 6 weeks earlier.
MindMed Upsizes Previously Announced Bought Deal Public Offering
MindMed's CAD$25-million bought deal financing becomes a $30 million financing -- the same day.